Question 1

What is Perspective Therapeutics, Inc.'s WACC?

Accepted Answer

Perspective Therapeutics, Inc. (CATX) has a Weighted Average Cost of Capital (WACC) of 9.81%. This is calculated using a Cost of Equity of 9.84% (via CAPM with a beta of 1.41) and a pre-tax Cost of Debt of 2.00%, with an equity weight of 99.63% in the capital structure.

Question 2

Is Perspective Therapeutics, Inc.'s WACC high or low?

Accepted Answer

Perspective Therapeutics, Inc.'s WACC of 9.81% falls within the typical 8-12% range for mid-cap growth companies. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Perspective Therapeutics, Inc.'s WACC calculated?

Accepted Answer

Perspective Therapeutics, Inc.'s WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 9.84% is derived from the CAPM model using a beta of 1.41. The pre-tax Cost of Debt (Rd) is 2.00%. The capital structure is 99.63% equity and 0.37% debt.

Perspective Therapeutics, Inc. (CATX) — WACC 分析

WACC 构成

解读

Perspective Therapeutics, Inc.（CATX）WACC：9.81%

WACC计算器

Perspective Therapeutics, Inc.（CATX） WACC 解读

CATX 公司分析

CATX DCF 估值

继续做同行对比